DrugDashboards

Guaifenesin and Dextromethorphan

Guaifenesin and Dextromethorphan · GUAIFENESIN 200 mg/10mL; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/10mL · Syrup · Oral · Major Pharmaceuticals

NDC 00904-7513-72 · 10 TRAY in 1 CASE / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE · OTC MONOGRAPH DRUG · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for guaifenesin and dextromethorphan (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
M012
TE code
—
Approval date
—
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Guaifenesin and Dextromethorphan (Syrup)

LabelerStrengthFirst seenLast seen
Cardinal Health 107, LLCGUAIFENESIN 100 mg/5mL; DEXTROMETHORPHAN 10 mg/5mLAug 26, 2026Sep 3, 2026
American Health PackagingGUAIFENESIN 100 mg/5mL; DEXTROMETHORPHAN 10 mg/5mLAug 26, 2026Sep 2, 2026
American Health PackagingGUAIFENESIN 200 mg/10mL; DEXTROMETHORPHAN 20 mg/10mLAug 26, 2026Sep 2, 2026
Major PharmaceuticalsGUAIFENESIN 100 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/5mLAug 26, 2026Sep 2, 2026
Major PharmaceuticalsGUAIFENESIN 200 mg/10mL; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/10mLAug 26, 2026Sep 2, 2026
PAI Holdings, LLC dba PAI PharmaGUAIFENESIN 100 mg/5mL; DEXTROMETHORPHAN 10 mg/5mLAug 26, 2026Sep 2, 2026
PAI Holdings, LLC dba PAI PharmaGUAIFENESIN 200 mg/10mL; DEXTROMETHORPHAN 20 mg/10mLAug 26, 2026Sep 2, 2026
Cardinal Health 107, LLCGUAIFENESIN 10 mg/5mL; DEXTROMETHORPHAN 100 mg/5mLJul 22, 2026Aug 21, 2026
American Health PackagingGUAIFENESIN 10 mg/5mL; DEXTROMETHORPHAN 100 mg/5mLJul 22, 2026Aug 19, 2026
American Health PackagingGUAIFENESIN 20 mg/10mL; DEXTROMETHORPHAN 200 mg/10mLJul 22, 2026Aug 19, 2026
Major PharmaceuticalsGUAIFENESIN 10 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 100 mg/5mLJul 22, 2026Aug 19, 2026
Major PharmaceuticalsGUAIFENESIN 20 mg/10mL; DEXTROMETHORPHAN HYDROBROMIDE 200 mg/10mLJul 22, 2026Aug 19, 2026
PAI Holdings, LLC dba PAI PharmaGUAIFENESIN 10 mg/5mL; DEXTROMETHORPHAN 100 mg/5mLJul 22, 2026Aug 19, 2026
PAI Holdings, LLC dba PAI PharmaGUAIFENESIN 20 mg/10mL; DEXTROMETHORPHAN 200 mg/10mLJul 22, 2026Aug 19, 2026
American Health PackagingDEXTROMETHORPHAN 10 mg/5mL; GUAIFENESIN 100 mg/5mLJul 15, 2026Jul 15, 2026
American Health PackagingDEXTROMETHORPHAN 20 mg/10mL; GUAIFENESIN 200 mg/10mLJul 15, 2026Jul 15, 2026
Cardinal Health 107, LLCDEXTROMETHORPHAN 10 mg/5mL; GUAIFENESIN 100 mg/5mLJul 15, 2026Jul 15, 2026
Major PharmaceuticalsDEXTROMETHORPHAN HYDROBROMIDE 10 mg/5mL; GUAIFENESIN 100 mg/5mLJul 15, 2026Jul 15, 2026
Major PharmaceuticalsDEXTROMETHORPHAN HYDROBROMIDE 20 mg/10mL; GUAIFENESIN 200 mg/10mLJul 15, 2026Jul 15, 2026
PAI Holdings, LLC dba PAI PharmaDEXTROMETHORPHAN 20 mg/10mL; GUAIFENESIN 200 mg/10mLJul 15, 2026Jul 15, 2026
PAI Holdings, LLC dba PAI PharmaDEXTROMETHORPHAN 10 mg/5mL; GUAIFENESIN 100 mg/5mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Guaifenesin and Dextromethorphan — NDC 00904-7513-72," retrieved September 3, 2026, https://drugdashboards.com/drug/00904751372.

Free to cite with attribution — see how the data is put together.